As Dr. Bing Xia emphasized, hit identification is highly target-dependent and is not best approached as a fixed route. Strategy selection should begin with the target context, including biological ...

The supergiant bathynomid is a deep-sea isopod famous for surviving more than five years without food. Despite residing in an ...

GoldQuest Mining Corp. (TSXV: GQC) (OTCQX: GDQMF) ("GoldQuest" or the "Company") is pleased to report assay results from five ...

On May 20, 2026, Viva Biotech hosted a V-Experts in Conversation webinar, "Managing Complexity in Modern Drug Discovery: A Practical Approach to Integrated ...

The speakers discussed how an integrated screening and medicinal chemistry workflow can support decision-making from hit identification through lead optimization. Dr. Xia emphasized that hit ...

GoldQuest Mining Corp. (TSXV: GQC) (OTCQX: GDQMF) ("GoldQuest" or the "Company") is pleased to report assay results from five metallurgical ...

Creative Diagnostics launches Humanized Control Antibodies to support the development of diagnostic assays for ...

Canterra Minerals Corporation (TSXV:CTM) (OTCQB: CTMCF) (FSE:DXZB) (“Canterra” or the “Company”) is pleased to report assay results from its winter drill program at the Buchans Project in the Central ...

Plus and Harvard analysis shows CNSide enables early diagnosis and better clinical decision-making reducing healthcare costs ...

Recently, a pharmaceutical company came to the antibody-discovery specialist, Abveris, with a serious problem. The pharmaceutical company had tried and failed to develop a monoclonal antibody for an ...

Machine learning is changing the front end of drug discovery, where researchers decide which targets to pursue and which molecules deserve costly laboratory work. Its deeper test lies further ...

Many diseases are driven by proteins interacting with each other inside cells. But blocking these interactions with drugs is ...